• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本肺部非结核分枝杆菌病全身和局部危险因素的患病率:一项单机构研究。

Prevalence of systemic and local risk factors for pulmonary non-tuberculous mycobacterial disease in Japan: a single-institution study.

作者信息

Kamei Ryohei, Sawahata Michiru, Nakayama Masayuki, Yamada Toshiyuki, Taniguchi Nobuyuki, Bando Masashi, Hagiwara Koichi

机构信息

Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University, Japan.

Department of Clinical Laboratory Medicine, Jichi Medical University, Japan.

出版信息

J Rural Med. 2023 Jul;18(3):168-174. doi: 10.2185/jrm.2023-001. Epub 2023 Jul 7.

DOI:10.2185/jrm.2023-001
PMID:37448701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10336341/
Abstract

To identify the prevalence of risk factors for pulmonary non-tuberculous mycobacterial (NTM) disease in a Japanese population. We reviewed 337 consecutive Japanese patients (210 women) with pulmonary NTM disease, including 225 patients with Mycobacterium avium complex (MAC) disease (95.8%) at our hospital during 2006-2017. We calculated the prevalence of risk factors reported in Western countries among mycobacterial species. Pulmonary MAC disease cases comprised 78.2% of pulmonary NTM patients in their 40s, increasing to 100% at age ≥80 years. Body mass index (BMI) was <18.5 in approximately 40% of patients, which was significantly higher than the prevalence of underweight in the Japanese population. The percentage of male heavy smokers (Brinkman index ≥600) was 58.2% of pulmonary NTM disease and was high for all mycobacterial species. In pulmonary MAC disease, systemic factors were observed in the order of malignant tumors (other than lung cancer), diabetes, rheumatoid arthritis, and tuberculosis. Local factors were observed in the order of bronchiectasis, chronic obstructive pulmonary disease, lung cancer, and bronchial asthma. The risk factors reported in Western countries were relatively highly prevalent among Japanese pulmonary NTM disease patients. This observation may help elucidate disease onset mechanisms.

摘要

确定日本人群中肺部非结核分枝杆菌(NTM)病危险因素的患病率。我们回顾了我院2006年至2017年间连续收治的337例日本肺部NTM病患者(210例女性),其中包括225例鸟分枝杆菌复合群(MAC)病患者(95.8%)。我们计算了西方国家报道的分枝杆菌菌种中危险因素的患病率。肺部MAC病病例在40多岁的肺部NTM患者中占78.2%,在≥80岁时增至100%。约40%的患者体重指数(BMI)<18.5,这显著高于日本人群中体重过轻的患病率。男性重度吸烟者( Brinkman指数≥600)在肺部NTM病患者中占58.2%,在所有分枝杆菌菌种中这一比例都很高。在肺部MAC病中,观察到的全身因素依次为恶性肿瘤(非肺癌)、糖尿病、类风湿关节炎和结核病。局部因素依次为支气管扩张、慢性阻塞性肺疾病、肺癌和支气管哮喘。西方国家报道的危险因素在日本肺部NTM病患者中相对较为普遍。这一观察结果可能有助于阐明疾病的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87c1/10336341/860e279e1ca2/jrm-18-168-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87c1/10336341/51563c65f6dd/jrm-18-168-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87c1/10336341/2861b186d409/jrm-18-168-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87c1/10336341/860e279e1ca2/jrm-18-168-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87c1/10336341/51563c65f6dd/jrm-18-168-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87c1/10336341/2861b186d409/jrm-18-168-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87c1/10336341/860e279e1ca2/jrm-18-168-g003.jpg

相似文献

1
Prevalence of systemic and local risk factors for pulmonary non-tuberculous mycobacterial disease in Japan: a single-institution study.日本肺部非结核分枝杆菌病全身和局部危险因素的患病率:一项单机构研究。
J Rural Med. 2023 Jul;18(3):168-174. doi: 10.2185/jrm.2023-001. Epub 2023 Jul 7.
2
[Non-tuberculous mycobacteriosis. What has been coming out].[非结核分枝杆菌病。最新进展]
Kekkaku. 2011 Feb;86(2):113-25.
3
[Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].[日本鸟分枝杆菌复合群感染控制策略:它们如何改善当前状况?]
Kekkaku. 2013 Mar;88(3):355-71.
4
[Treatment of non-tuberculous pulmonary mycobacteriosis].[非结核分枝杆菌肺病的治疗]
Kekkaku. 2006 Jan;81(1):35-50.
5
Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.日本一家转诊医院中,非结核分枝杆菌肺病和结核病的流行病学和临床特征的相互关系变化。
Respir Med. 2019 Jun;152:74-80. doi: 10.1016/j.rmed.2019.05.001. Epub 2019 May 8.
6
A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013.2012 至 2013 年日本基于实验室的非结核分枝杆菌肺病分析。
Ann Am Thorac Soc. 2017 Jan;14(1):49-56. doi: 10.1513/AnnalsATS.201607-573OC.
7
Clinical relevance of pulmonary non-tuberculous mycobacterial isolates in three reference centres in Belgium: a multicentre retrospective analysis.比利时三个参考中心的肺部非结核分枝杆菌分离株的临床相关性:一项多中心回顾性分析。
BMC Infect Dis. 2019 Dec 17;19(1):1061. doi: 10.1186/s12879-019-4683-y.
8
Clinical findings in relation to mortality in non-tuberculous mycobacterial infections: patients with Mycobacterium avium complex have better survival than patients with other mycobacteria.非结核分枝杆菌感染的临床发现与死亡率的关系:鸟分枝杆菌复合群患者的生存率高于其他分枝杆菌患者。
Eur J Clin Microbiol Infect Dis. 2015 Sep;34(9):1909-18. doi: 10.1007/s10096-015-2432-8. Epub 2015 Jul 9.
9
Increasing patients with pulmonary Mycobacterium avium complex disease and associated underlying diseases in Japan.日本肺部鸟分枝杆菌复合群疾病及相关基础疾病患者人数不断增加。
J Infect Chemother. 2015 May;21(5):352-6. doi: 10.1016/j.jiac.2015.01.004. Epub 2015 Jan 9.
10
[The clinical analysis of chronic obstructive pulmonary disease patients complicated with nontuberculous mycobacterial pulmonary disease].[慢性阻塞性肺疾病合并非结核分枝杆菌肺病患者的临床分析]
Zhonghua Jie He He Hu Xi Za Zhi. 2019 Nov 12;42(11):826-831. doi: 10.3760/cma.j.issn.1001-0939.2019.11.008.

本文引用的文献

1
A retrospective study of factors associated with treatment decision for nontuberculous mycobacterial lung disease in adults without altered systemic immunity.一项与无免疫功能改变的成人非结核分枝杆菌肺病治疗决策相关因素的回顾性研究。
BMC Infect Dis. 2018 Dec 14;18(1):659. doi: 10.1186/s12879-018-3559-x.
2
Epidemiology of pulmonary disease due to nontuberculous mycobacteria in Southern China, 2013-2016.中国南方地区非结核分枝杆菌肺病的流行病学研究,2013-2016 年。
BMC Pulm Med. 2018 Nov 9;18(1):168. doi: 10.1186/s12890-018-0728-z.
3
Risk factors and secondary care utilisation in a primary care population with non-tuberculous mycobacterial disease in the UK.
在英国,初级保健人群中非结核分枝杆菌病的风险因素和二级保健利用情况。
Eur J Clin Microbiol Infect Dis. 2019 Jan;38(1):117-124. doi: 10.1007/s10096-018-3402-8. Epub 2018 Oct 27.
4
Low body mass index and lymphocytopenia associate with Mycobacterium avium complex pulmonary disease in patients with rheumatoid arthritis.低体重指数和淋巴细胞减少与类风湿关节炎患者的鸟分枝杆菌复合群肺病相关。
Mod Rheumatol. 2019 Jan;29(1):105-112. doi: 10.1080/14397595.2018.1452334. Epub 2018 Apr 9.
5
Causative species of nontuberculous mycobacterial lung disease and comparative investigation on clinical features of Mycobacterium abscessus complex disease: A retrospective analysis for two major hospitals in a subtropical region of Japan.非结核分枝杆菌肺病的致病菌种及脓肿分枝杆菌复合群疾病临床特征的比较研究:日本亚热带地区两家主要医院的回顾性分析
PLoS One. 2017 Oct 23;12(10):e0186826. doi: 10.1371/journal.pone.0186826. eCollection 2017.
6
Body habitus in patients with and without bronchiectasis and non-tuberculous mycobacteria.患有和未患有支气管扩张及非结核分枝杆菌的患者的体型。
PLoS One. 2017 Sep 28;12(9):e0185095. doi: 10.1371/journal.pone.0185095. eCollection 2017.
7
Mortality after Respiratory Isolation of Nontuberculous Mycobacteria. A Comparison of Patients Who Did and Did Not Meet Disease Criteria.非结核分枝杆菌呼吸道隔离后的死亡率。符合疾病标准与不符合疾病标准患者的比较。
Ann Am Thorac Soc. 2017 Jul;14(7):1112-1119. doi: 10.1513/AnnalsATS.201610-800OC.
8
Mycobacterium kansasii.堪萨斯分枝杆菌。
Microbiol Spectr. 2017 Jan;5(1). doi: 10.1128/microbiolspec.TNMI7-0011-2016.
9
Epidemiology of Pulmonary Nontuberculous Mycobacterial Disease, Japan.日本肺部非结核分枝杆菌病的流行病学
Emerg Infect Dis. 2016 Jun;22(6):1116-7. doi: 10.3201/eid2206.151086.
10
Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review.人类非结核分枝杆菌肺部感染的流行病学:综述
Clin Chest Med. 2015 Mar;36(1):13-34. doi: 10.1016/j.ccm.2014.10.002. Epub 2014 Nov 6.